KEROS THERAPEUTICS INC

Ticker: KROS CUSIP: 492327101 Class: Common Stock

MACKENZIE FINANCIAL CORP's Holding History (CIK: 0000919859)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 51,385 Value ($000) $1,040 Avg Close $17.54 Range $13.60 - $22.55
Q3 2025
Shares 56,768 Value ($000) $898 Avg Close $14.77 Range $13.13 - $16.30
Q2 2025
Shares 53,877 Value ($000) $719 Avg Close $13.50 Range $9.12 - $15.40